Generate Biomedicines 与 Zealand Pharma 达成合作与许可协议,为肥胖及其他代谢疾病设计多特异性候选药物,初期启动两个项目,并保留第三个项目的选择权。
We’re partnering with Zealand Pharma to design multispecific drug candidates for obesity and other metabolic diseases across two initial programs, with an option for a third.
We will start with what a drug candidate needs to do for patients, then design toward that profile. Their decades of data, paired with our generative models and high-throughput experimental measurement, will guide the design of multispecific drug candidates with the biological functions we want to achieve.
Read the news release → https://generatebiomedicines.com/news-releases/generate-biomedicines-and-zealand-pharma-enter-collaboration-and-license-agreement-to-develop-protein-therapeutics-engineered-with-ai-for-metabolic-diseases/
来源:Generate:Biomedicines · x.com